Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 0, No 0 - Annals of Internal Medicine

Background: Randomized controlled trials established the cardiac protection of sodium–glucose cotransporter-2 (SGLT2) inhibitors among adults with type 2 diabetes. New evidence suggests that these results could extend to people without diabetes. Purpose: To e…

Affiliations: Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China… [+3166 chars]

full article...